How Speed, Scale, and Science Can Personalize the Pandemic Response
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
False
Advertisement
Development & Clinical
New START for Kumar Muthalagappan
January 20, 2026
Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally
2 min read
First Preclinical Development Candidate for Nucleome Therapeutics
January 19, 2026
First-in-class monoclonal antibody agonist program for inflammation
2 min read
Schistosomiasis: The Need for a Tailored-Made Treatment for Preschoolers
January 15, 2026
About the Pediatric Praziquantel Consortium, and why a child-friendly treatment for preschool-aged children with schistosomiasis was needed
13 min read
Does the Role of CDMO Need to Evolve?
By Stephanie Vine
January 14, 2026
In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions
7 min read
The Future of Precision Medicine is Radiopharmaceuticals
By Mona-Elisabeth Rootwelt-Revheim
January 12, 2026
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
5 min read
A Turning Point in MASH
By HH Kim
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
New Approach Methodologies: Why the Future of Drug Development Must Be Human
By Hayley Gooding
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech
By Heather Purvis
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
How Mixing FSP and FSO Models Bring Agility to Modern Clinical Development
By Les Enterline
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
